A number of cell surface markers have been used to sort for breast cancer cells with tumor-initiating capacity, including CD44 [6], CD133 [37], ALDH [31,38], CD90 [39,40], and CD117 (KIT) [41]. This evidence concerns the gene CD44 and neoplasm.